Literature DB >> 11956181

Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase.

Keisuke Wakasugi1, Bonnie M Slike, John Hood, Karla L Ewalt, David A Cheresh, Paul Schimmel.   

Abstract

The first step of protein synthesis is catalyzed by aminoacyl-tRNA synthetases. In addition, certain mammalian tRNA synthetases link protein synthesis to cytokine signaling pathways. In particular, human tyrosyl-tRNA synthetase (TyrRS) can be split by proteolysis into two fragments having distinct cytokine activities. One of the TyrRS fragments (mini TyrRS) contains features identical to those in CXC chemokines (like interleukin-8) that also act as angiogenic factors. Here mini TyrRS (but not full-length TyrRS) is shown to stimulate chemotaxis of endothelial cells in vitro and stimulate angiogenesis in each of two in vivo animal models. The angiogenic activity of mini TyrRS can be opposed by anti-angiogenic chemokines like IP-10. Thus, a biological fragment of human tyrosyl-tRNA synthetase links protein synthesis to regulation of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956181     DOI: 10.1074/jbc.C200126200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping.

Authors:  Sunghoon Kim; Sungyong You; Daehee Hwang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses.

Authors:  Tarun Kumar Bhatt; Sameena Khan; Ved Prakash Dwivedi; Mudassir Meraj Banday; Arvind Sharma; Anmol Chandele; Noelia Camacho; Lluís Ribas de Pouplana; Yang Wu; Alister G Craig; Antti Tapani Mikkonen; Alexander Gerd Maier; Manickam Yogavel; Amit Sharma
Journal:  Nat Commun       Date:  2011-11-08       Impact factor: 14.919

3.  Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine.

Authors:  Quansheng Zhou; William B Kiosses; Jin Liu; Paul Schimmel
Journal:  Methods       Date:  2008-02       Impact factor: 3.608

4.  Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development.

Authors:  Wiebke Herzog; Katja Müller; Jan Huisken; Didier Y R Stainier
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

Review 5.  Aminoacyl tRNA synthetases and their connections to disease.

Authors:  Sang Gyu Park; Paul Schimmel; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

Review 6.  Aminoacyl-tRNA synthetase complexes: molecular multitasking revealed.

Authors:  Corinne D Hausmann; Michael Ibba
Journal:  FEMS Microbiol Rev       Date:  2008-06-03       Impact factor: 16.408

7.  Small interfering RNA knockdown of mini-TyrRS and mini-TrpRS effects angiogenesis in human umbilical vein endothelial cells in hypoxic culture.

Authors:  Rui Zeng; Yu-Cheng Chen; Zhi Zeng; Rui Liu; Ou Qiang; Xiao-Fei Jiang; Xiao-Xia Liu; Xian Li; Hao-Yu Wang
Journal:  Cytotechnology       Date:  2008-06-19       Impact factor: 2.058

8.  VEGF, not VEGFR2, is associated with the angiogenesis effect of mini-TyrRS/mini-TrpRS in human umbilical vein endothelial cells in hypoxia.

Authors:  Rui Zeng; Xiao-Fei Jiang; Yu-Cheng Chen; Yuan-Ning Xu; Song-Hong Ma; Zhi Zeng; Rui Liu; Ou Qiang; Xian Li
Journal:  Cytotechnology       Date:  2013-07-30       Impact factor: 2.058

9.  Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality.

Authors:  Quansheng Zhou; Mili Kapoor; Min Guo; Rajesh Belani; Xiaoling Xu; William B Kiosses; Melanie Hanan; Chulho Park; Eva Armour; Minh-Ha Do; Leslie A Nangle; Paul Schimmel; Xiang-Lei Yang
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

10.  A domain for editing by an archaebacterial tRNA synthetase.

Authors:  Kirk Beebe; Eve Merriman; Lluis Ribas De Pouplana; Paul Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.